Estados financieros detallados de NeuroOne Medical Technologies Corporation (NMTC): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
NeuroOne Medical Technologies Corporation registró ingresos de $12.1M en el último ejercicio fiscal, con un CAGR de 5 años del 44.4%.
Márgenes de los últimos 12 meses: margen bruto 55.7%, margen operativo -76.1%, margen neto -71.5%.
Al precio actual de $1.41, NMTC presenta beneficios negativos (P/E no significativo) y un ROE del -126.45%. La capitalización bursátil es de $12M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | $1.9M | $178146 | $171169 | $2.0M | $3.5M | $12.1M |
| Coste de Ventas | $7740 | $17633 | $21667 | $27569 | $70552 | $275895 | $241963 | $1.5M | $2.4M | $4.0M |
| Beneficio Bruto | -$7740 | -$17633 | -$21667 | -$27569 | $1.9M | -$97749 | -$70794 | $456517 | $1.1M | $8.1M |
| I+D | 0 | $735333 | $951064 | $1.5M | $2.1M | $3.9M | $4.9M | $6.9M | $5.1M | $5.0M |
| Generales y Administrativos | $32611 | $2.3M | $3.5M | $4.3M | $4.8M | $6.3M | $7.0M | $6.9M | $7.9M | $7.4M |
| Gastos Operativos | $32611 | $3.1M | $3.2M | $5.8M | $6.8M | $10.1M | $10.0M | $12.4M | $13.0M | $12.4M |
| Beneficio Operativo | -$32611 | -$3.1M | -$3.2M | -$5.8M | -$4.9M | -$10.2M | -$10.0M | -$12.0M | -$11.9M | -$4.2M |
| EBITDA | -$32611 | -$3.1M | -$4.1M | -$5.8M | -$4.9M | -$9.8M | -$9.9M | -$11.7M | -$11.8M | -$3.0M |
| Gastos por Intereses | 0 | $1.4M | 0 | $284557 | $7.5M | $3053 | 0 | 0 | $228988 | $334063 |
| Beneficio Antes de Impuestos | -$32611 | -$5.1M | -$6.8M | -$6.8M | -$13.6M | -$9.9M | -$10.0M | -$11.9M | -$12.3M | -$3.6M |
| Impuestos | $15164 | 0 | $3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$47775 | -$5.1M | -$6.8M | -$6.8M | -$13.6M | -$9.9M | -$10.0M | -$11.9M | -$12.3M | -$3.6M |
| BPA | $-0.17 | $-13.80 | $-14.58 | $-10.32 | $-15.12 | $-5.58 | $-3.78 | $-3.90 | $-2.76 | $-0.54 |
| BPA Diluido | $-0.17 | $-13.80 | $-14.58 | $-10.32 | $-15.12 | $-5.58 | $-3.78 | $-3.90 | $-2.76 | $-0.54 |
| Acciones en Circulación (Diluidas) | $281833 | $367226 | $467807 | $658754 | $902563 | $1.8M | $2.7M | $3.0M | $4.5M | $6.7M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $2.7M | $2.9M | $2.4M | $2.0M |
| Beneficio Bruto | $1.5M | $1.6M | $1.3M | $1.2M |
| Beneficio Operativo | -$1.4M | -$1.7M | -$2.1M | -$2.4M |
| EBITDA | -$1.6M | -$1.4M | -$2.0M | -$2.0M |
| Beneficio Neto | -$1.6M | -$1.4M | -$2.1M | -$2.0M |
| BPA | $-0.26 | $-0.17 | $-0.25 | $-0.23 |
| BPA Diluido | $-0.26 | $-0.17 | $-0.25 | $-0.23 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $522217 | $26467 | $13260 | $260749 | $4.0M | $6.9M | $8.2M | $5.3M | $1.5M | $6.6M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $3.0M | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | $48336 | $33237 | 0 | $176636 | $1.3M |
| Inventario | 0 | 0 | 0 | 0 | 0 | $98287 | $704538 | $1.7M | $2.6M | $2.2M |
| Activos Corrientes | $576040 | $33613 | $18638 | $301751 | $4.2M | $7.3M | $12.2M | $7.3M | $4.6M | $10.2M |
| Inmovilizado Material | 0 | 0 | 0 | $52026 | $448242 | $512277 | $534954 | $694812 | $671753 | $514417 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $180890 | $216372 | $200081 | $178838 | $156523 | $134207 | $111892 | $89577 | $67262 | $44946 |
| Activos Totales | $756930 | $249985 | $218719 | $532615 | $4.8M | $7.9M | $12.8M | $8.1M | $5.4M | $10.8M |
| Cuentas por Pagar | $22362 | 0 | $221235 | $1.2M | $762538 | $528829 | $927662 | $685104 | $1.0M | $1.0M |
| Deuda a Corto | $275197 | $2.4M | $1.7M | 0 | $1.0M | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $677190 | $3.9M | $3.8M | $1.8M | $2.4M | $1.2M | $3.1M | $1.8M | $2.2M | $2.3M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.0M | $5.3M | $4.6M | $1.8M | $2.7M | $1.4M | $3.2M | $1.8M | $4.5M | $3.7M |
| Reservas | -$266370 | -$5.3M | -$10.5M | -$17.2M | -$30.9M | -$40.8M | -$50.8M | -$62.7M | -$75.0M | -$78.6M |
| Patrimonio Neto | -$266220 | -$5.0M | -$4.4M | -$1.2M | $2.1M | $6.6M | $9.6M | $6.2M | $822013 | $7.1M |
| Deuda Total | $275197 | $2.4M | $1.7M | 0 | $1.3M | $315673 | $202895 | $184400 | $260160 | $266806 |
| Deuda Neta | -$247020 | $2.4M | $1.7M | -$260749 | -$2.7M | -$6.6M | -$10.9M | -$5.1M | -$1.2M | -$6.3M |
| Capital Circulante | -$101150 | -$3.9M | -$3.8M | -$1.5M | $1.8M | $6.1M | $9.1M | $5.5M | $2.4M | $7.9M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $6.6M | $3.6M | $2.8M | $2.0M |
| Activos Totales | $10.8M | $8.6M | $7.9M | $6.2M |
| Pasivos Totales | $3.7M | $2.2M | $2.5M | $2.4M |
| Patrimonio Neto | $7.1M | $6.4M | $5.4M | $3.8M |
| Deuda Total | $266806 | $237377 | $206973 | $73320 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$47775 | -$5.1M | -$6.8M | -$6.8M | -$13.6M | -$9.9M | -$10.0M | -$11.9M | -$12.3M | -$3.6M |
| Amortizaciones | $7740 | $17633 | $20556 | $27569 | $47609 | $80748 | $118620 | $199266 | $246791 | $261679 |
| Compensación en Acciones | 0 | $76794 | $486120 | $491749 | $1.8M | $1.8M | $947212 | $1.1M | $1.3M | $1.3M |
| Cambio en Capital Circulante | $11052 | $859892 | $1768 | -$101881 | -$429563 | -$512733 | $1.2M | -$2.4M | -$954611 | -$429191 |
| Flujo de Caja Operativo | -$21106 | -$2.1M | -$2.8M | -$5.4M | -$3.4M | -$8.6M | -$7.5M | -$12.9M | -$11.0M | -$2.8M |
| Inversiones (CapEx) | 0 | -$91709 | 0 | -$123352 | -$122427 | -$67079 | -$275226 | -$384117 | -$120197 | -$81742 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | $3.0M | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$119419 | -$81403 | -$124617 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$21106 | -$2.2M | -$2.8M | -$5.5M | -$3.5M | -$8.7M | -$7.8M | -$13.3M | -$11.1M | -$2.9M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$1.5M | -$3.1M | -$1.3M | -$1.1M |
| Inversiones (CapEx) | -$10607 | -$40754 | -$38519 | -$19659 |
| Flujo de Caja Libre | -$1.5M | -$3.2M | -$1.4M | -$1.1M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $358560 | $359255 | $342135 | $352777 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | | | -90.8% | -3.9% | +1040.7% | +76.9% | +250.4% |
| Crecimiento Beneficio Neto (anual) | | -10488.0% | -35.0% | +0.7% | -101.1% | +27.1% | -0.5% | -18.6% | -3.9% | +70.7% |
| Crecimiento BPA (anual) | | -8027.2% | -5.7% | +29.2% | -46.5% | +63.1% | +32.3% | -3.2% | +29.2% | +80.4% |
| Cambio en Acciones (anual) | | +30.3% | +27.4% | +40.8% | +37.0% | +97.5% | +49.6% | +13.3% | +47.7% | +50.0% |
| Crecimiento FCF (anual) | | -10322.5% | -28.5% | -95.2% | +35.7% | -144.4% | +10.1% | -70.3% | +16.1% | +73.8% |
| Margen Bruto | | | | | 96.3% | -54.9% | -41.4% | 23.4% | 31.3% | 67.3% |
| Margen Operativo | | | | | -254.5% | -5735.9% | -5860.2% | -612.3% | -344.3% | -34.9% |
| Margen EBITDA | | | | | -252.0% | -5500.0% | -5772.7% | -597.2% | -343.0% | -24.9% |
| Margen Neto | | | | | -708.0% | -5584.3% | -5842.0% | -607.4% | -356.7% | -29.8% |
| Margen FCF | | | | | -184.1% | -4866.7% | -4553.8% | -679.7% | -322.4% | -24.1% |
| Tasa Impositiva Efectiva | -46.5% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.07 | $-5.99 | $-6.04 | $-8.38 | $-3.93 | $-4.86 | $-2.92 | $-4.39 | $-2.50 | $-0.44 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $281833 | $367226 | $467807 | $658754 | $902563 | $1.8M | $2.7M | $3.0M | $4.5M | $6.7M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -126.45% |
| Rentabilidad sobre capital invertido | -183.45% |
| Rentabilidad sobre activos | -115.57% |
| Margen bruto | 55.67% |
| Margen operativo | -76.05% |
| Margen neto | -71.51% |
Salud financiera
| Deuda / Patrimonio | 0.02 |
| Ratio corriente | 2.84 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -426.15 | -5.24 | -6.79 | -3.26 | -1.53 | -4.25 | -2.68 | -1.37 | -2.15 | -9.87 |
| P/VC | -76.60 | -5.28 | -10.54 | -17.92 | 10.12 | 6.45 | 2.82 | 2.58 | 32.23 | 5.04 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 10.85 | 237.18 | 157.96 | 8.26 | 7.67 | 2.95 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 96.3% | -54.9% | -41.4% | 23.4% | 31.3% | 67.3% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | -254.5% | -5735.9% | -5860.2% | -612.3% | -344.3% | -34.9% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | -708.0% | -5584.3% | -5842.0% | -607.4% | -356.7% | -29.8% |